- Home
- UPXI vs RXST Comparison
UPXI vs RXST Comparison
Compare UPXI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- RXST
- Stock Information
- Founded
- UPXI 2018
- RXST 1997
- Country
- UPXI United States
- RXST United States
- Employees
- UPXI N/A
- RXST N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UPXI Health Care
- RXST Health Care
- Exchange
- UPXI Nasdaq
- RXST Nasdaq
- Market Cap
- UPXI 339.4M
- RXST 317.0M
- IPO Year
- UPXI 2021
- RXST 2021
- Fundamental
- Price
- UPXI $5.25
- RXST $7.67
- Analyst Decision
- UPXI
- RXST Hold
- Analyst Count
- UPXI 0
- RXST 12
- Target Price
- UPXI N/A
- RXST $18.45
- AVG Volume (30 Days)
- UPXI 12.9M
- RXST 2.1M
- Earning Date
- UPXI 05-16-2025
- RXST 08-07-2025
- Dividend Yield
- UPXI N/A
- RXST N/A
- EPS Growth
- UPXI N/A
- RXST N/A
- EPS
- UPXI N/A
- RXST N/A
- Revenue
- UPXI $16,562,327.00
- RXST $148,310,000.00
- Revenue This Year
- UPXI $299.03
- RXST N/A
- Revenue Next Year
- UPXI N/A
- RXST $10.73
- P/E Ratio
- UPXI N/A
- RXST N/A
- Revenue Growth
- UPXI 1378.83
- RXST 46.70
- 52 Week Low
- UPXI $1.90
- RXST $6.32
- 52 Week High
- UPXI $22.57
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- UPXI 44.64
- RXST 31.54
- Support Level
- UPXI $4.31
- RXST $7.55
- Resistance Level
- UPXI $6.50
- RXST $7.99
- Average True Range (ATR)
- UPXI 1.07
- RXST 0.37
- MACD
- UPXI -0.05
- RXST 0.25
- Stochastic Oscillator
- UPXI 15.21
- RXST 46.73
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.